Corvel CRVL Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period

Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period at other companies

Medline, Inc. MDLN

0—

Revenue$248.5M+7.4%

Gross profit$63.0M+8.3%

Net income$31.0M+17.4%

EPS (diluted)$0.61+19.6%

Cash & equivalents$233.1M+36.6%

Total debt$28.1M+0.1%

Total equity$394.2M+22.4%

Total assets$643.0M+17.8%

Operating cash flow$29.5M+28.6%

CapEx$9.2M+5.9%

Free cash flow$20.3M+42.3%

Market cap$3.03B-51.4%

Enterprise value$2.82B-53.8%

P/E27.4×-38.0×

P/S3.2×-3.8×

Gross margin24.3%+0.9pp

Net margin11.5%+0.9pp

FCF margin11.5%+1.3pp

Return on equity30.8%-2.6pp

Debt / equity0.1×0.0×

Current ratio2×+0.1×

Reported directly by Corvel in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod.

The official record: Corvel’s 10-Q, filed February 5, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Corvel's share-based compensation arrangement by share-based payment award, options, forfeitures in period?: Corvel (CRVL) reported share-based compensation arrangement by share-based payment award, options, forfeitures in period of 4.7K in Q4 2025.
How has Corvel's share-based compensation arrangement by share-based payment award, options, forfeitures in period changed year-over-year?: Corvel's share-based compensation arrangement by share-based payment award, options, forfeitures in period decreased by 32.3% year-over-year, from 6.9K to 4.7K.